ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
The US-based big pharma MSD has entered the race to be the first to develop…
Vienna-based Themis Bioscience will develop vaccine candidates against an undisclosed disease target in partnership with…
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much…
MSD is back in the RNA field with the acquisition of Rigontec, a German biotech…
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
Noxxon Pharma has teamed up with the NCT in Heidelberg to conduct a Phase I/II…
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some…
Even more Big Pharma join the fight to acquire the extremely desirable Medivation, a Biotech developing…
MSD has received EMA pre-approval for its famous anti-PD-1 therapy, Keytruda. It could soon be…
I'm a UK Expat in Berlin, and whilst I admit confusion over where exactly the…
Cancer Research UK has teamed up with MSD (Merck) and the Wellcome Trust to co-develop some…